Chris Koopmans

MRVL President and COO Chris Koopmans sells 10,000 shares ($2.8M) under pre-arranged 10b5-1 plan; 4-month sell pattern continues despite +154.0% stock run

Chris Koopmans sold 10,000 shares of Marvell at $281.92 on 2026-07-01 as part of a pre-arranged 10b5-1 trading plan adopted on 2026-01-05, reducing his holdings from 237.8K to 227.8K shares. This is the fourth consecutive sell over four months (June, May, April, and now July 2026), following prior sales at MRVL that averaged +32.2%, +26.0%, and +56.2% 30-day returns respectively. The scheduled nature of this trade removes any discretionary timing signal, but the sustained multi-month sell cadence coincides with exceptional stock performance: Marvell has delivered +154.0% 90-day returns and a +24.0% 30-day gain, trading near the top of its 52-week range ($61.44–$329.88). The company's fundamentals show strong revenue growth at +42.1% annually with a $2.4B quarterly revenue base, though the P/E of 94.13 reflects elevated valuation. The pattern of repeated sales during an extended bull run warrants attention to the predetermined execution schedule and its alignment with broader market timing.

Marvell's President and COO Chris Koopmans sold 10,000 shares at $205.87 under pre-arranged 10b5-1 plan; still holds 237,392 shares post-transaction.

Chris Koopmans sold 10,000 shares (10.0K shares) for $2,058,700.00 ($2.1M) on 2026-06-01 under a pre-arranged 10b5-1 trading plan adopted 2026-01-05, reducing his holdings from 247,392 shares (247.4K shares) to 237,392 shares (237.4K shares). Because the transaction is scheduled under a 10b5-1 plan rather than discretionary, it does not reflect a timed market decision. His prior sales at MRVL show varying outcomes: the most recent sale on 2026-05-01 saw the stock rise +26.0% over 90 days, while an earlier sale on 2026-04-06 was followed by +86.0% gains over 90 days, but a 2025-02-18 sale preceded a -41.2% decline over the same period. The company reported net income of $1,901,300,000.00 ($1.9B) on revenue of $2,074,500,000.00 ($2.1B) in the latest quarter, with annual revenue growth of +42.1%, yet trades at a P/E of 31.80 relative to a $191,847,649,000.00 ($191.8B) market cap.

Marvell COO Koopmans sold 10.0K shares at $162.76; 10b5-1 plan, stock now +37.1% in 30d

Chris Koopmans, President and COO of Marvell Technology, executed a 10,000-share sale on 2026-05-01 at $162.76, part of a pre-arranged 10b5-1 trading plan adopted on 2026-01-05, meaning the transaction was scheduled and not driven by current discretionary conviction. The current stock price of $183.52 reflects a +37.1% 30-day and +133.5% 90-day gain, substantially outpacing the sale price, which signals the market has re-rated MRVL positively since the plan was established. Koopmans' prior sell timing record shows a 50% well-timed rate, and while this particular sale occurred before recent momentum, the underlying fundamentals—revenue of $2,074,500,000 with 42.1% annual growth and net income of $1,901,300,000—support the strong performance. The scheduled nature of this disposition under 10b5-1 precludes interpreting it as an insider capitulation signal, though it may reflect rebalancing or liquidity needs rather than confidence in current valuations.

Marvell COO Chris Koopmans sold 10,000 shares at $110.24 on 2026-04-06 per 10b5-1 plan; holds 133,870 shares post-sale

Chris Koopmans, President and COO of Marvell Technology, sold 10,000 shares worth $1,102,400.00 pursuant to a pre-arranged 10b5-1 trading plan. This sale reduced his post-transaction holdings to 133,870 shares from 143,870 shares, representing a -7.0% decrease in his position. Because this transaction is governed by a scheduled trading plan rather than discretionary decision-making, it carries limited inferential value regarding executive conviction or market outlook at the time of execution.

Marvell President and COO Koopmans Chris buys 6,800 shares ($530.6K) at $78.03; cluster buy by 3 other insiders in past 14 days

Chris Koopmans, President and COO of Marvell Technology, purchased 6,800 shares at $78.03 on 2025-09-25, bringing his holdings to 104,825 shares, a 6.9% increase. The timing coincides with a broader insider cluster: 3 other insiders also purchased shares within the past 14 days, suggesting coordinated confidence at current valuations. However, context tempers the signal: Koopmans' prior sell on 2025-02-18 at MRVL was well-timed, with the stock declining 41.2% over the following 90 days, indicating his prior trade judgment was accurate but that the current buy is occurring in a stock that has fallen 33.5% from its 52-week high and that was unprofitable over its most recent full fiscal year despite posting $2.0B in quarterly revenue. The coincidence of a cluster buy with recent steep price declines and negative full-year earnings raises questions about whether this reflects conviction or reflects a different set of considerations.

COO Chris Koopmans sold 6,000 shares of MRVL at $106.35 on 2025-02-18; holds 87,931 shares post-sale

Chris Koopmans, Chief Operating Officer of Marvell Technology, sold 6,000 shares (6.0K shares) at $106.35 for $638,100.00 on 2025-02-18, reducing his holdings by 6.4% to 87,931 shares. The sale occurred at a price $4.69 below the current price of $111.04 and represents a discrete transaction during a period of mixed momentum: the stock is down 11.0% over the past 30 days but up 19.5% over 90 days, trading 11.9% below its 52-week high of $126.06. The timing merits scrutiny given that the company faces material headwinds—full-year net income was negative at $-676.3M, annual revenue contracted 7.0% year-over-year, and the latest quarterly revenue of $1.5B reflects ongoing profitability challenges. A discretionary open-market sale by the COO during a period of corporate unprofitability and revenue decline is a data point for investors monitoring insider positioning and confidence during operational stress.